Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>CICC: CN Commercial Health Insurance Development Expected to Usher in New Era w/ Focus on 4 Key Areas
Recommend 22 Positive 40 Negative 14 |
||||
|
||||
|
Insurers were popular today, with CHINA LIFE (02628.HK) advancing 5.5% to $33.96. PING AN (02318.HK) jumped up 2.5%, while CPIC (02601.HK) leaped 2.8%. AIA (01299.HK) ballooned 3.9% to $86.25. Last Thursday (22nd), the Insurance Association of China (IAC), the China Association of Actuaries (CAA) and the China Banking and Insurance Information Technology Management jointly issued a document saying that they will improve key infrastructure in areas such as commercial health insurance pricing data, product design, drug catalogs and information sharing based on their respective functions, CICC recently published a research report saying. Meanwhile, the Insurance Asset Management Association of China (IAMAC) also issued a statement clarifying the insurance industry's long-term investment support for the healthcare sector. Previously, in its series report on China's commercial health insurance, CICC discussed how commercial health insurance has fallen into the vicious cycle of low product value creation and funding efficiency—insufficient payment capacity struggles to leverage medical resources—making it difficult to enhance product value creation and funding efficiency. This cycle stems from the combined effects of numerous long-standing, top-down obstacles. The broker believed that this policy package directly addresses key bottlenecks, effectively guiding the industry toward a positive feedback and ushering in a new era of development. CICC recommended investors to focus on investment opportunities in the following areas: (1) leading internet platforms and giant insurance groups committed to and with the potential to build systemic projects for commercial insurance payments; (2) leading brokerage channels and related entities deeply involved in the more efficient corporate group insurance sector; (3) reinsurers and insurers that continued to build health insurance management capabilities or benefit from the development of the health insurance market; (4) pharmaceutical upstream and downstream enterprises benefiting from the incremental commercial insurance payments. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
